Financhill
Back

Direxion Dly CSI 300 CHN A Shr Bl 2X ETF Vs. Kymera Therapeutics Industry Stock Comparison

Sell
34

CHAU
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF

Last Price:
16.46
Seasonality Move:
6.2%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.38
Seasonality Move:
65.72%
Sell
34
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF (CHAU) is a Sell

Is Direxion Dly CSI 300 CHN A Shr Bl 2X ETF a Buy, Sell or Hold?

  • The current Direxion Dly CSI 300 CHN A Shr Bl 2X ETF [CHAU] share price is $14.80. The Score for CHAU is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CHAU is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CHAU Stock Price Chart

What is Direxion Dly CSI 300 CHN A Shr Bl 2X ETF's stock price today?

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

CHAU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.63 Buy
Relative Strength Index (14 RSI): 44.63 Sell
Chaikin Money Flow: 881149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.29 - 20.77) Sell
Bollinger Bands (100): (11.25 - 16.57) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

CHAU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.01 Sell
20-day SMA: 17.73 Sell
50-day SMA: 14.48 Buy
200-day SMA: 13.82 Buy
8-day EMA: 16.88 Sell
20-day EMA: 17.02 Sell
50-day EMA: 15.46 Sell
200-day EMA: 14.58 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Direxion Dly CSI 300 CHN A Shr Bl 2X ETF Earnings Growth & CHAU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Direxion Dly CSI 300 CHN A Shr Bl 2X ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):